Initial Experience of Clinical Use of [<sup>99m</sup>Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
Numerous different molecules of prostate-specific membrane antigen (PSMA) ligands are used to detect prostate cancer (PCa); most approaches utilize gallium PET and a few reports describe the role of SPECT/CT. [<sup>99m</sup>Tc]Tc-PSMA-T4 is a new radiopharmaceutical designed for the diag...
Saved in:
Main Authors: | Jarosław B. Ćwikła (Author), Marek Roslan (Author), Iwona Skoneczna (Author), Monika Kempińska-Wróbel (Author), Michał Maurin (Author), Wojciech Rogowski (Author), Barbara Janota (Author), Anna Szarowicz (Author), Piotr Garnuszek (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024) -
Radiosynthesis and Preclinical Evaluation of [<sup>99m</sup>Tc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
by: Syeda Marab Saleem, et al.
Published: (2024) -
[<sup>99m</sup>Tc]Tc-Labeled Plectin-Targeting Peptide as a Novel SPECT Probe for Tumor Imaging
by: Jiali Gong, et al.
Published: (2022) -
Development of the <sup>99m</sup>Tc-Labelled SST<sub>2</sub> Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study
by: Doroteja Novak, et al.
Published: (2023) -
In Vitro Hemocompatibility and Genotoxicity Evaluation of Dual-Labeled [<sup>99m</sup>Tc]Tc-FITC-Silk Fibroin Nanoparticles for Biomedical Applications
by: María Alejandra Asensio Ruiz, et al.
Published: (2023)